sam altman artificial intelligence

Sam Altman fires back

Sam Altman-Elon Musk Feud Timeline: AI Billionaires Bark Over Trump-Endorsed Stargate AI Project

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

The Associated Press on MSN · 1d

Musk clashes with OpenAI CEO Sam Altman over Trump-supported Stargate AI data center project

Elon Musk is clashing with OpenAI CEO Sam Altman over the Stargate artificial intelligence infrastructure project touted by President Donald Trump, the latest in a feud between the two billionaires that started on OpenAI’s board and is now testing

Interesting Engineering · 1h

‘Wrong’: Sam Altman fires back after Elon Musk questions $500B Stargate funding

Musk’s criticisms have escalated into legal actions. In February, he filed a lawsuit against OpenAI, accusing it of breaching its nonprofit mandate. Although the lawsuit was withdrawn in June, Musk refiled it in August, further intensifying the conflict.

Altman Tells ChatGPT Fans To Stop The Hype On AGI & Superintelligence

OpenAI CEO Sam Altman is battling rumors surrounding superintelligence and AGI (artificial general intelligence). Is ChatGPT ...

eWeek3d

Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...

5don MSN

Sam Altman says the kid he’s expecting soon will never be smarter than AI, but thinks this ability will be valuable

"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...

10d

Sam Altman predicts artificial superintelligence (AGI) will happen this year

Alan Thompson, an expert in artificial intelligence and former chairman of Mensa International, runs the Conservative ...

Sam Altman-backed Retro Biosciences to raise $1bn for longevity mission

Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results